These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Factors affecting the direct targeting of murine leukemia virus vectors containing peptide ligands in the envelope protein. Katane M, Takao E, Kubo Y, Fujita R, Amanuma H. EMBO Rep; 2002 Sep; 3(9):899-904. PubMed ID: 12189179 [Abstract] [Full Text] [Related]
12. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes. Weijtens ME, Willemsen RA, Hart EH, Bolhuis RL. Gene Ther; 1998 Sep; 5(9):1195-203. PubMed ID: 9930320 [Abstract] [Full Text] [Related]
13. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Stitz J, Buchholz CJ, Engelstädter M, Uckert W, Bloemer U, Schmitt I, Cichutek K. Virology; 2000 Jul 20; 273(1):16-20. PubMed ID: 10891403 [Abstract] [Full Text] [Related]
14. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles. Höhne M, Thaler S, Dudda JC, Groner B, Schnierle BS. Virology; 1999 Aug 15; 261(1):70-8. PubMed ID: 10441556 [Abstract] [Full Text] [Related]
19. Inter-retroviral fusion mediated by human immunodeficiency virus or murine leukemia virus glycoproteins: independence of cellular membranes and membrane vesicles. Sparacio S, Pfeiffer T, Holtkotte D, Bosch V. Virology; 2002 Mar 15; 294(2):305-11. PubMed ID: 12009872 [Abstract] [Full Text] [Related]
20. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein. Zavorotinskaya T, Albritton LM. Mol Ther; 2001 Mar 15; 3(3):323-8. PubMed ID: 11273774 [Abstract] [Full Text] [Related] Page: [Next] [New Search]